Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER-NZAus Randomized Placebo-Controlled Trial
- PMID: 37333836
- PMCID: PMC10236542
- DOI: 10.1016/j.ympdx.2019.100009
Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER-NZAus Randomized Placebo-Controlled Trial
Abstract
We evaluated the effect of antenatal sildenafil on neonatal cardiovascular function in a subgroup of 27 infants of mothers participating in the STRIDER-NZAus randomized controlled trial. In this small study, we found no association between antenatal sildenafil and neonatal cardiac dysfunction including no pulmonary hypertension in exposed or unexposed infants.
© 2019 The Authors.
References
-
- Paauw N.D., Terstappen F., Ganzevoort W., Joles J.A., Gremmels H., Lely A.T. Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure. Hypertension. 2017;70:998–1006. - PubMed
-
- von Dadelszen P., Dwinnell S., Magee L.A., Carleton B.C., Gruslin A., Lee B., et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118:624–628. - PubMed
-
- Groom K.M., McCowan L.M., Mackay L.K., Lee A.C., Gardener G., Unterscheider J., et al. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction. BJOG. 2019;126:997–1006. - PubMed
-
- Sharp A., Cornforth C., Jackson R., Harrold J., Turner M.A., Kenny L.C., et al. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health. 2018;2:93–102. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
